Importantly, this re-introduction of RCN1 led to these cells displaying increased survival compared to the #41-SCD cell line after tunicamycin or thapsigargin treatment (Figure 4E,F). This evidence concerns the gene RCN1 and Schnyder corneal dystrophy.